Key Challenges & Considerations in the Transition from Pre-clinical to FIH clinical studies in Neurologic indications
Time: 12:00 pm
day: Day One: Track B AM
Details:
The plan for this expert panel discussion is to focus on the challenges and considerations that companies face as the emerge from Discovery/Pre-clinical work and plan to enter First in Human (FIH) studies requiring support from their GMP manufacturing programs/partners, clinical development, and engagement with patient communities in the planning and early execution of clinical research.
Speakers:
As a member of the physician scientist community, I am thrilled to lead the Rare Disease & Pediatrics work across therapeutic areas within our broad range of clinical research services and, specifically, in the evolution of our medical communities development efforts within the targeted areas encompassed by gene therapy. As a member of a global…Read more
